Aptose Biosciences (TSE:APS) Shares Pass Below 200 Day Moving Average – Time to Sell?

Aptose Biosciences Inc. (TSE:APS) (NASDAQ:APTO) shares crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of C$11.11 and traded as low as C$5.39. Aptose Biosciences shares last traded at C$5.46, with a volume of 708 shares trading hands.

Analysts Set New Price Targets

Separately, Alliance Global Partners raised shares of Aptose Biosciences to a “strong-buy” rating in a report on Thursday, February 27th.

Aptose Biosciences Stock Performance

The company has a market cap of C$243.71 million, a P/E ratio of -1.13 and a beta of 1.36. The stock has a fifty day moving average price of C$7.18 and a two-hundred day moving average price of C$11.04. The company has a debt-to-equity ratio of -117.37, a current ratio of 1.05 and a quick ratio of 5.41.

Aptose Biosciences Company Profile

Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.